These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 10201366)
21. Design of biologically active heparan sulfate and heparin using an enzyme-based approach. Peterson S; Frick A; Liu J Nat Prod Rep; 2009 May; 26(5):610-27. PubMed ID: 19387498 [TBL] [Abstract][Full Text] [Related]
22. Mechanism of low-molecular-weight heparin reversal by platelet factor 4. Fiore MM; Mackie IM Thromb Res; 2009 May; 124(1):149-55. PubMed ID: 19195682 [TBL] [Abstract][Full Text] [Related]
23. The relationship between the structure of dermatan sulfate derivatives and their antithrombotic activities. Du HY; Ji SL; Song HF; Ye QN; Cao JC Thromb Res; 2007; 119(3):377-84. PubMed ID: 17097136 [TBL] [Abstract][Full Text] [Related]
25. In vitro evaluation of synthetic heparin-like conjugates comprising different thrombin binding domains. Basten JE; Dreef-Tromp CM; de Wijs B; van Boeckel CA Bioorg Med Chem Lett; 1998 May; 8(10):1201-6. PubMed ID: 9871735 [TBL] [Abstract][Full Text] [Related]
26. Preparation and use of microarrays containing synthetic heparin oligosaccharides for the rapid analysis of heparin-protein interactions. Noti C; de Paz JL; Polito L; Seeberger PH Chemistry; 2006 Nov; 12(34):8664-86. PubMed ID: 17066397 [TBL] [Abstract][Full Text] [Related]
27. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design. Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442 [TBL] [Abstract][Full Text] [Related]
28. Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans. Noti C; Seeberger PH Chem Biol; 2005 Jul; 12(7):731-56. PubMed ID: 16039522 [TBL] [Abstract][Full Text] [Related]
29. An Efficient Modular One-Pot Synthesis of Heparin-Based Anticoagulant Idraparinux. Dey S; Lo HJ; Wong CH J Am Chem Soc; 2019 Jul; 141(26):10309-10314. PubMed ID: 31244187 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological activities of octyl 2,3-di-O-sulfo-alpha-L-fucopyranosyl-(1-->3)-2-O-sulfo-alpha-L-fucopyranosyl-(1-->4)-2,3-di-O-sulfo-alpha-L-fucopyranosyl-(1-->3)-2-O-sulfo-alpha-L-fucopyranosyl-(1-->4)-2,3-di-O-sulfo-beta-L-fucopyranoside. Hua Y; Du Y; Yu G; Chu S Carbohydr Res; 2004 Aug; 339(12):2083-90. PubMed ID: 15280053 [TBL] [Abstract][Full Text] [Related]
31. Phenolic P2/P3 core motif as thrombin inhibitors--design, synthesis, and X-ray co-crystal structure. Hanessian S; Therrien E; van Otterlo WA; Bayrakdarian M; Nilsson I; Fjellström O; Xue Y Bioorg Med Chem Lett; 2006 Feb; 16(4):1032-6. PubMed ID: 16290930 [TBL] [Abstract][Full Text] [Related]
32. [A new generation of anticoagulants: design, synthesis and pharmacologic profile of thrombin inhibtors]. Schmid G; Ackermann J; Banner D; Gast A; Gubernator K; Hadváry P; Hilpert K; Labler L; Tschopp T J Pharm Belg; 1995; 50(2-3):188-93. PubMed ID: 7674118 [No Abstract] [Full Text] [Related]
33. Insights into the induced fit mechanism in antithrombin-heparin interaction using molecular dynamics simulations. Verli H; Guimarães JA J Mol Graph Model; 2005 Dec; 24(3):203-12. PubMed ID: 16146701 [TBL] [Abstract][Full Text] [Related]